Medicare Enrolled
Dr. David Rybnicek, M.D.
Gastroenterology · Hendersonville, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rybnicek from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rybnicek?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rybnicek
Dr. David Rybnicek is a gastroenterology specialist in Hendersonville, NC, with 14 years of NPI registration. Based on federal Medicare data, Dr. Rybnicek performed 9,312 Medicare services across 1,236 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rybnicek received a total of $6,189 from 36 pharmaceutical and/or device companies across 349 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rybnicek is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ Top 3% volume in NC
$6,189 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,312
Medicare services
Top 3% in NC for gastroenterology
1,236
Unique beneficiaries
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~665 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Vedolizumab infusion (Entyvio) This procedure involves the administration of vedolizumab via injection. The dosage is measured in milligrams. |
7,507 | $17 | $35 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
392 | $36 | $100 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
247 | $55 | $1,350 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
227 | $191 | $1,800 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
226 | $48 | $150 |
| Balloon dilation of esophagus, stomach, or upper small bowel, less than 3.0 cm A procedure using a flexible endoscope to widen a narrowed section of the esophagus, stomach, or upper small bowel with a balloon that is less than 3.0 cm in length. |
92 | $93 | $800 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
87 | $90 | $2,000 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
77 | $100 | $500 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
53 | $170 | $1,500 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
50 | $130 | $1,600 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
50 | $68 | $400 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
44 | $56 | $300 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
42 | $62 | $300 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
33 | $118 | $600 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
33 | $168 | $1,000 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
29 | $99 | $400 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
26 | $44 | $200 |
| Endoscopy of digestive tract Imaging of the digestive tract performed from the inside using an endoscope. |
20 | $534 | $2,800 |
| Upper endoscopy (EGD) A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope. |
18 | $83 | $1,100 |
| Endoscopic removal of bile or pancreatic duct stone A flexible endoscope is used to remove stones or debris from the bile or pancreatic ducts. |
17 | $119 | $2,000 |
| Removal of large bowel tissue using flexible endoscope A procedure to remove tissue from the large intestine using a flexible tube with a camera. The endoscope allows the provider to access and excise the tissue directly. |
17 | $263 | $2,294 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
14 | $84 | $350 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
11 | $14 | $100 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
81.2% high complexity
5.5% medium
13.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,189
Total received (2018-2024)
Avg $884/year across 7 years
Top 26% in NC for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
349
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,189 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,427
2023
$1,287
2022
$1,099
2021
$878
2020
$606
2019
$708
2018
$184
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$273
Gilead Sciences, Inc.
$171
Takeda Pharmaceuticals U.S.A., Inc.
$134
IRONWOOD PHARMACEUTICALS, INC
$126
PENTAX of America, Inc.
$93
Phathom Pharmaceuticals, Inc.
$87
GENZYME CORPORATION
$74
Janssen Biotech, Inc.
$59
Daiichi Sankyo Inc.
$48
PFIZER INC.
$45
Celltrion USA Inc.
$44
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$44
Olympus America Inc.
$43
Intercept Pharmaceuticals, Inc.
$42
Regeneron Healthcare Solutions, Inc.
$41
Lilly USA, LLC
$32
Madrigal Pharmaceuticals
$26
QOL Medical, LLC
$22
Organon Llc
$22
Top 3 companies account for 40.5% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie Inc.
$921
Takeda Pharmaceuticals U.S.A., Inc.
$695
ABBVIE INC.
$654
PENTAX of America, Inc.
$518
Gilead Sciences, Inc.
$449
Janssen Biotech, Inc.
$386
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$360
Ironwood Pharmaceuticals, Inc
$313
IRONWOOD PHARMACEUTICALS, INC
$170
PFIZER INC.
$169
AbbVie, Inc.
$144
GENZYME CORPORATION
$142
Ferring Pharmaceuticals Inc.
$135
INTERCEPT PHARMACEUTICALS, INC.
$109
Celgene Corporation
$107
Regeneron Healthcare Solutions, Inc.
$93
Nestle HealthCare Nutrition Inc.
$90
Phathom Pharmaceuticals, Inc.
$87
Intercept Pharmaceuticals, Inc.
$76
Olympus America Inc.
$72
Daiichi Sankyo Inc.
$70
Endogastric Solutions, Inc
$63
Romark Laboratories, LC
$54
Celltrion USA Inc.
$44
QOL Medical, LLC
$41
Lilly USA, LLC
$32
UCB, Inc.
$28
Madrigal Pharmaceuticals
$26
Organon Llc
$22
Merck Sharp & Dohme LLC
$20
Braintree Laboratories, Inc.
$20
Merck Sharp & Dohme Corporation
$18
Fresenius Kabi USA, LLC
$17
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
Alfasigma USA, Inc.
$16
INTRA-SANA LABORATORIES
$10
Top 3 companies account for 36.7% of all-time payments
Associated products mentioned in payments ›
ALINIA · Alinia · CIMZIA · CREON · CYLTEZO · Cimzia · DIFICID · DUPIXENT · ENTYVIO · EOHILIA · ESOPHYX · EndoClot PHS · Entyvio · Epclusa · GATTEX · HADLIMA · HUMIRA · Humira · IDACIO · IMAGINA · INJECTAFER · INSPIRA · LINZESS · Linzess · MAVYRET · MOTEGRITY · Mavyret · Motegrity · OCALIVA · OMVOH · PLENVU · REBYOTA · RELISTOR · RELTONE 200 MG · REMICADE · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUTAB · Sucraid · TREMFYA · VEGZELMA · VISIGLIDE · VOQUEZNA · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA · ZYMFENTRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Gastroenterologists within 10 mi
38
Per 100K population
32.4
County median income
$67,623
Nearest hospital
PARDEE HOSPITAL HENDERSON COUNTY
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rybnicek is a mixed practice specialist, with above-average Medicare volume (top 3% in NC), with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rybnicek experienced with vedolizumab infusion (entyvio)?
Based on Medicare claims data, Dr. Rybnicek performed 7,507 vedolizumab infusion (entyvio) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rybnicek receive payments from pharmaceutical companies?
Yes. Dr. Rybnicek received a total of $6,189 from 36 companies across 349 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rybnicek's costs compare to other gastroenterologists in Hendersonville?
Dr. Rybnicek's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rybnicek) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Hendersonville
Browse gastroenterologists in Hendersonville ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in NC
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in NC
Which NC gastroenterologists receive the most from drug and device companies.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology